This is a single-site, prospective, non-randomized and open label study to investigate the feasibility of home-use CVS for the prevention of episodic migraine headache and specifically to better understand what type of waveform to apply.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Enrollment
3
Non-invasive neurostimulator, home-use treatment for up to 43 days.
Duke Medicine / Neurology
Durham, North Carolina, United States
Number of migraine headache days
Daily Headache Diary will be used by subject. A headache day is defined as a twenty-four hour period which the subject has a headache.
Time frame: Length of the study, about 71 days
Severity of each and of all headaches
Daily Headache Diary will be used by subject. Subject will assign the level of pain based on an eleven-point pain measurement scale from zero (no pain) to ten (most intense pain).
Time frame: Length of study, 71 days
Total Monthly Headache Pain Score
The monthly measure would be the cumulative maximal headache pain scores for all headache days (days on which the subject's head pain level is one or higher on the pain measurement scale) during the month.
Time frame: Length of study, about 71 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.